Skip to main content

Table 1 Baseline characteristics of 260 patients with systolic heart failure

From: Prognostic value of alveolar volume in systolic heart failure: a prospective observational study

Characteristic Number or Median (Percent or IQR)
Age, years 68 (58–75)
Male gender 207 (80)
BMI, kg/m2 26 (24–29)
Current smoker 50 (19)
NYHA class III-IV 84 (32)
LVEF, % 32 (25–40)
Cardiothoracic ratio >0.5 162 (62)
NT-ProBNP, pg/mL 1302 (531–3028)
Hemoglobin, g/dL 13.7 (12.4–14.9)
Creatinine, mmol/L 101 (82–127)
FEV1, % predicted 87 (72–101)
DLCO, % predicted 70 (61–81)
COPD 65 (25)
Ventilatory restriction 53 (20)
Coronary artery disease 115 (44)
Hypertension 141 (54)
Persistent atrial fibrillation 51 (20)
Prior stroke 21 (8)
Diabetes 82 (32)
Dyslipidemia 109 (42)
Beta-blockers 223 (86)
ACE-inhibitors 150 (58)
Angiotensin receptor antagonists 75 (29)
Loop diuretics 225 (87)
Potassium sparing drugs 175 (67)
Warfarin 42 (16)
Implanted pace-maker 35 (13)
Implanted defibrillator 13 (5)
  1. IQR = interquartile range. BMI = body mass index. NYHA = New York Heart Association. LVEF = left ventricular ejection fraction. NT-proBNP = N-terminal pro-hormone of B type natriuretic peptide. FEV1 = forced expiratory volume in one second. DLCO = diffusing capacity of the lung for carbon monoxide. COPD = chronic obstructive pulmonary disease. ACE = angiotensing converting enzyme.